Analystreport

Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at Aegis. They set a "buy" rating and a $10.00 price target on the stock.

Evogene Ltd. - Ordinary Shares  (EVGN) 
Last evogene ltd. - ordinary shares earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: evogene.com/investor-relations